0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

THE NATURE OF SPECIFIC HEMOLYSINS AND STANDARD METHOD OF PREPARING ANTISHEEP HEMOLYSIN

L. G. HADJOPOULOS, M.D.
Arch Intern Med (Chic). 1921;27(4):441-448. doi:10.1001/archinte.1921.00100100057005.
Text Size: A A A
Published online

From the time of the discovery of specific antibodies and their subsequent application to the so-called complement fixation tests, the study of specific hemolysins has especially attracted the attention of numerous investigators.

As early as 1875, Landois,1 in the course of transfusion experiments, noticed the toxic (hemolytic) effect of alien serums on the erythrocytes of the recipients. But our knowledge of specific hemolysins dates back to 1898, when Belfanti and Carbone,2 and almost simultaneously Bordet,3 published their observations on the gradually acquired hemolytic properties of serums of animals injected with erythrocytes of other species.

Following the above observations, more important facts about the multiplicity of such lytic antibodies were disclosed, and so, the general interest was more concentrated on bacteriolysins and other kinds of cytolysins that have to do more directly with the all important question of immunity and anaphylaxis. This resulted in a partial neglect of the equally important

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 4

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();